Solara Active Pharma Sciences Limited (BOM:890202)

BOM:890202 Statistics

Total Valuation

BOM:890202 has a market cap or net worth of INR 27.93 billion. The enterprise value is 34.29 billion.

Market Cap	27.93B
Enterprise Value	34.29B

Important Dates

The last earnings date was Friday, May 15, 2026.

Earnings Date	May 15, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+10.54%
Shares Change (QoQ)	-0.36%
Owned by Insiders (%)	10.02%
Owned by Institutions (%)	24.08%
Float	33.11M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.03
PB Ratio	2.22
P/TBV Ratio	3.23
P/FCF Ratio	27.91
P/OCF Ratio	18.27
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 17.78, with an EV/FCF ratio of 34.26.

EV / Earnings	-462.80
EV / Sales	2.49
EV / EBITDA	17.78
EV / EBIT	36.78
EV / FCF	34.26

Financial Position

The company has a current ratio of 0.96, with a Debt / Equity ratio of 0.55.

Current Ratio	0.96
Quick Ratio	0.55
Debt / Equity	0.55
Debt / EBITDA	3.56
Debt / FCF	6.86
Interest Coverage	0.98

Financial Efficiency

Return on equity (ROE) is -0.63% and return on invested capital (ROIC) is 4.92%.

Return on Equity (ROE)	-0.63%
Return on Assets (ROA)	2.55%
Return on Invested Capital (ROIC)	4.92%
Return on Capital Employed (ROCE)	6.48%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	7.75M
Profits Per Employee	-41,746
Employee Count	1,775
Asset Turnover	0.60
Inventory Turnover	2.15

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +18.28% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+18.28%
50-Day Moving Average	332.82
200-Day Moving Average	386.34
Relative Strength Index (RSI)	50.76
Average Volume (20 Days)	144

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BOM:890202 had revenue of INR 13.75 billion and -74.10 million in losses. Loss per share was -1.68.

Revenue	13.75B
Gross Profit	6.91B
Operating Income	932.30M
Pretax Income	-74.10M
Net Income	-74.10M
EBITDA	1.93B
EBIT	932.30M
Loss Per Share	-1.68

Balance Sheet

The company has 533.40 million in cash and 6.87 billion in debt, with a net cash position of -6.33 billion.

Cash & Cash Equivalents	533.40M
Total Debt	6.87B
Net Cash	-6.33B
Net Cash Per Share	n/a
Equity (Book Value)	12.56B
Book Value Per Share	287.12
Working Capital	-358.10M

Cash Flow

In the last 12 months, operating cash flow was 1.53 billion and capital expenditures -528.20 million, giving a free cash flow of 1.00 billion.

Operating Cash Flow	1.53B
Capital Expenditures	-528.20M
Depreciation & Amortization	996.80M
Net Borrowing	-1.20B
Free Cash Flow	1.00B
FCF Per Share	n/a

Margins

Gross margin is 50.22%, with operating and profit margins of 6.78% and -0.54%.

Gross Margin	50.22%
Operating Margin	6.78%
Pretax Margin	-0.54%
Profit Margin	-0.54%
EBITDA Margin	14.03%
EBIT Margin	6.78%
FCF Margin	7.28%

Dividends & Yields

BOM:890202 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-10.54%
Shareholder Yield	-10.54%
Earnings Yield	-0.27%
FCF Yield	3.58%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	7